vimarsana.com
Home
Live Updates
Switzerlandi august
Live Breaking News & Updates on Switzerlandi august
Novartis Scemblix®, with novel mechanism of action, approved by the European Commission for adult patients with chronic myeloid leukemia | Small Molecules
Novartis Scemblix®, with novel mechanism of action, approved by the European Commission for adult patients with chronic myeloid leukemia
Germany
,
Norway
,
Iceland
,
Japan
,
United-states
,
United-kingdom
,
Philadelphia
,
Pennsylvania
,
Vienna
,
Wien
,
Austria
,
Liechtenstein
Novartis provides update on Phase III CANOPY-A study evaluating canakinumab as adjuvant treatment in non-small cell lung cancer | Antibodies
Novartis provides update on Phase III CANOPY-A study evaluating canakinumab as adjuvant treatment in non-small cell lung cancer
United-states
,
American
,
Biochim-biophys-acta
,
Jeff-legos
,
Global-head-of-oncology-hematology-development
,
American-joint-committee-on-cancer
,
World-health-organization
,
American-cancer-society
,
Union-for-international-cancer-control
,
Novartis
,
Switzerlandi-august
,
Executive-vice-president